Showing results (231-240 of 447) with videos related to
Sort By:
Pageof 45
Cardio-Oncology (London, England)|February 14, 2025
Macrotroponin interference and association with cardiotoxicity in patients receiving cardiotoxic breast cancer therapy: a pilot studyAndrea Soosaipillai, Inbar Nardi-Agmon, Davor Brinc, et al.Cardio-Oncology (London, England)|February 22, 2025
Cancer and myocardial injury in patients with suspected acute coronary syndromeMarta Sabaté-Tormos, Alfredo Bardají, Oscar M Peiró, et al.Cardio-Oncology (London, England)|February 22, 2025
Percutaneous coronary intervention-lobectomy for Lung Cancer hybrid surgery: an initial case seriesJing Zeng, Junyi Yu, Qiao Mei, et al.Cardio-Oncology (London, England)|November 4, 2024
Accuracy of mitral annular plane systolic excursion in diagnosing anthracycline-induced subclinical cardiotoxicity in patients with breast cancer - a retrospective cohort studyLuís Fábio Barbosa Botelho, Marcelo Dantas Tavares de Melo, André Luiz Cerqueira de Almeida, et al.Cardio-Oncology (London, England)|October 29, 2024
Unsupervised machine learning identifies distinct phenotypes in cardiac complications of pediatric patients treated with anthracyclinesXander Jacquemyn, Bhargava K Chinni, Benjamin T Barnes, et al.Cardio-Oncology (London, England)|October 31, 2025
Right ventricular vulnerability: a case study on anthracycline-induced cardiotoxicity post-pulmonary embolism recoveryCheavar A Blair, Bryana M Levitan, Tori Brown, et al.Cardio-Oncology (London, England)|October 31, 2025
A call to action: improving access to cardiac MRI for diagnosis of immune checkpoint inhibitor related myocarditis in low and middle income countriesAruni Ghose, Abhinav Kandala, Isha Sabnis, et al.Cardio-Oncology (London, England)|October 14, 2025
Efficacy and cardiovascular safety of liposomal doxorubicin: a systematic review and meta-analysis of randomized trialsGermano Dallegrave Cavalli, Jose P Lopez-Lopez, Frances Caringal Carandang, et al.Cardio-Oncology (London, England)|October 10, 2025
Evaluation of the cardiotoxicity risk based on the HFA-ICOS score in a group of sub-Saharan African women before breast cancer treatment by chemotherapy and/or radiotherapy: a cross-sectional study in a group of Cameroonian womenChris Nadège Nganou-Gnindjio, Etienne Atenguena Okobalemba, Loic Alban Tasong, et al.Cardio-Oncology (London, England)|September 24, 2025
Evaluation of a screening algorithm to detect cardiac amyloidosis in mild to severe aortic valve stenosisFabian Voß, Elric Zweck, Jean Marc Haurand, et al.Pageof 45